Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 3 | 2 | — | — | 5 |
Primary myelofibrosis | D055728 | — | D47.4 | 1 | 2 | 1 | — | — | 4 |
Myelodysplastic syndromes | D009190 | — | D46 | — | 2 | 1 | — | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 9 | 1 | — | — | — | 10 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 4 | 3 | — | — | — | 6 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 4 | 1 | — | — | — | 4 |
Multiple myeloma | D009101 | — | C90.0 | 2 | 1 | — | — | — | 3 |
Thyroid neoplasms | D013964 | EFO_0003841 | — | — | 1 | — | — | 1 | 2 |
Neuroblastoma | D009447 | EFO_0000621 | — | 1 | 1 | — | — | — | 2 |
Gastrointestinal stromal tumors | D046152 | EFO_0000505 | C49.A | — | 1 | — | — | — | 1 |
Gastrointestinal neoplasms | D005770 | — | C26.9 | — | 1 | — | — | — | 1 |
Paraneoplastic syndromes | D010257 | — | — | — | 1 | — | — | — | 1 |
Islet cell adenoma | D007516 | EFO_0007331 | D13.7 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 3 | — | — | — | — | 3 |
Lymphoproliferative disorders | D008232 | Orphanet_2442 | D47.9 | 2 | — | — | — | — | 2 |
Colonic neoplasms | D003110 | — | C18 | 1 | — | — | — | — | 1 |
Rectal neoplasms | D012004 | — | — | 1 | — | — | — | — | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | — | — | — | — | 1 |
Esophageal neoplasms | D004938 | — | C15 | 1 | — | — | — | — | 1 |
Central nervous system neoplasms | D016543 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Imetelstat |
INN | imetelstat |
Description | Imetelstat (development code GRN163L) is an experimental anticancer drug. The first telomerase inhibitor to enter clinical trials, As of early 2023, it was in Phase 2/3 trials for various cancer types.[which?]
|
Classification | Oligonucleotide |
Drug class | enzyme inhibitors: telomerase inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 868169-64-6 |
RxCUI | — |
ChEMBL ID | CHEMBL2107856 |
ChEBI ID | — |
PubChem CID | 71587831 |
DrugBank | DB05036 |
UNII ID | F60NE4XB53 (ChemIDplus, GSRS) |